Aclaris Therapeutics Announces Issuance of US Patent Covering a JAK Inhibitor for Treating Hair Loss Disorders
Aclaris Therapeutics Announces Issuance of US Patent Covering a JAK Inhibitor for Treating Hair Loss Disorders GlobeNewswire (press release) Aclaris Therapeutics (ACRS) Announces US Patent for JAK Inhibitor to Treat Hair Loss StreetInsider.com Aclaris experimental hair loss treatment gets additional patent protection Philadelphia Business Journal Full coverage